Frontlight ResearchEarly access
Trial site
Huntington Memorial Hospital
- 12running trials
- 2closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Ovarian cancer3 trials
- Triple-negative breast cancer3 trials
- Atrial fibrillation2 trials
- Stroke2 trials
- Aortic stenosis1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Endometrial cancer1 trial
- Melanoma1 trial
- Obesity1 trial
- Sarcoma1 trial
- Phase
- Phase 38 trials
- Phase 21 trial
- Status
- Recruiting7 trials
- Active, not recruiting5 trials
- Completed1 trial
- Withdrawn1 trial
- Lead sponsor
- NRG Oncology3 trials
- Abbott Medical Devices2 trials
- Alliance for Clinical Trials in Oncology2 trials
- National Cancer Institute (NCI)2 trials
- Canadian Cancer Trials Group1 trial
- and 4 more
Running trials
Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
Active, not recruiting
Active, not recruiting
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ovarian cancer2 recruiting
- Triple-negative breast cancer2 recruiting
- Endometrial cancer1 recruiting
- Melanoma1 recruiting
- Sarcoma1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026